|
|
|
 |
|
|
 |
 |
Emisphere Technologies Incorporated
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Emisphere Technologies Incorporated. The Group's principal activity is developing product candidates for therapeutic areas, including cardiovascular disease, diabetes, osteoporosis, growth disorders, asthma and allergies, obesity and infectious diseases. It has not yet obtained the regulatory approval for sales of any of its product candidates. It has drug candidates in development stage namely, Oral Unfractionated Heparin and Oral Low Molecular Weight Heparin for Cardivascular, Oral Salmon Calcitonin and Oral Recombinant Parathyroid Hormone for Osteoporosis, Partner proprietary small molecule compounds for Bone-related diseases, Oral Recombinant Human Growth Hormone for Growth Disorders, Oral Insulin & Oral Glucagon-Like Peptides for Diabetes, Oral Cromolyn Sodium for Asthma/Allergies, Oral Ciliary Neutrophic Growth Factor and Oral PYY3-36 for Obesity and Oral Anthrax Antigen for Anti-infectives. The Group has operations in the United States.
|
|
| |
Wright Quality Rating:
LDNN Rating Explanations |
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (2/5/2010):
.98
(Figures in
U.S. Dollars) |
|
1 Week |
-11.7% |
|
13 Weeks |
-19.0% |
|
|
|
|
|
|
|
|
|
4 Weeks |
44.1% |
|
52 Weeks |
92.2% |
|
|
|
| |
| |
Emisphere Technologies Incorporated
Key Data: |
|
|
|
| |
Ticker: |
EMIS |
Country: |
UNITED STATES |
| |
|
| |
Exchanges: |
OTC |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Ethical Drug Manufacturers |
| |
|
| |
2008
Sales |
251,000
(Year Ending Jan 2009). |
Employees: |
20 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
41,228,993 |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
42,070,401 |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
12,351,220 |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Emisphere Technologies Incorporated, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Emisphere Technologies Incorporated company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Emisphere Technologies Incorporated Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Emisphere Technologies Incorporated
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Emisphere Technologies Incorporated Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|